Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 16 Oct 2017 |
2 | Reply to Exam Report (MIS-R) | 30 Nov 2017 |
3 | Reply to Exam Report (MIS-R) | 04 Dec 2017 |
4 | Authorization Letter | 22 Apr 2019 |
5 | Journal Copy | 26 Jun 2019 |
6 | TM-O(NOTICE OF OPPOSITION) | 20 Aug 2019 |
7 | Evidence Affidavit Under Rule 45 (TOP) | 24 Dec 2019 |
8 | Evidence Affidavit Under Rule 46 (TOP) | 22 Feb 2020 |
9 | Annexure -1 under rule 46 | 22 Feb 2020 |
1 | Hearing Notice (Show Cause) | 7896719 | 3952664 | 05 Mar 2019 |
2 | Tribunal Accepted Notice for : 3658647 | 8153423 | 4004782 | 22 Apr 2019 |
3 | Opposition Notice | 8850648 | 4360828 | 29 Aug 2019 |
4 | Opposition Counter Statement | 9163219 | 4498146 | 28 Oct 2019 |
Trademark was applied on 16 October 2017 with IP India.
Proprietor of Lamotem is EMCURE PHARMACEUTICALS.
Class(es) in which the trademark was applied to is 5.
Status of Lamotem is Opposed.
Application number alloted to the trademark is 3658647.
Aditya & Associates is the Trademark agent/attorney.
Trademark has been filed in the following category:
WORD